Assessment of the Prevalence of Olfactory Disorders in Systemic Scleroderma

Stopped Following the COVID-related health crisis, nasofibroscopic sampling could no longer be carried out

Conditions

• Olfactory Disorders
• Scleroderma

Interventions

• DIAGNOSTIC_TEST: olfactory testing with specific odorants (localisation and identification)

Sponsor

University Hospital, Lille